Screener
Intellia Therapeutics NTLA Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Intellia Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's price / sales?
- Intellia Therapeutics (NTLA) reported price / sales of 39.7× in Q2 2026.
- How has Intellia Therapeutics's price / sales changed year-over-year?
- Intellia Therapeutics's price / sales increased by 111.8% year-over-year, from 18.8× to 39.7×.
- What is the long-term trend for Intellia Therapeutics's price / sales?
- Over 5 years (2020 to 2025), Intellia Therapeutics's price / sales has grown at a -26.1% compound annual growth rate (CAGR), from 69.8× to 15.4×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Intellia Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude